Vanguard Group Inc Neuronetics, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Neuronetics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,306,070 shares of STIM stock, worth $9.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,306,070

Previous 1,281,390 79.97%

Holding current value

$9.02 Million

Previous $1.91 Million 344.53%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$1.49 - $5.54 $1.53 Million - $5.68 Million	1,024,680 Added 79.97%	2,306,070 $8.49 Million
Q4 2024 Feb 11, 2025	SELL	$0.59 - $1.49 $10,929 - $27,602	-18,525 Reduced 1.43%	1,281,390 $1.91 Million
Q1 2024 May 10, 2024	SELL	$2.68 - $4.8 $142,653 - $255,499	-53,229 Reduced 3.93%	1,299,915 $6.19 Million
Q1 2023 May 15, 2023	BUY	$2.81 - $6.71 $590,139 - $1.41 Million	210,014 Added 18.37%	1,353,144 $3.94 Million
Q4 2022 Feb 10, 2023	SELL	$2.74 - $6.87 $5,973 - $14,976	-2,180 Reduced 0.19%	1,143,130 $7.85 Million
Q3 2022 Nov 14, 2022	BUY	$2.35 - $4.66 $26,089 - $51,735	11,102 Added 0.98%	1,145,310 $3.64 Million
Q2 2022 Aug 12, 2022	BUY	$2.09 - $3.71 $141,056 - $250,391	67,491 Added 6.33%	1,134,208 $3.64 Million
Q1 2022 May 13, 2022	SELL	$2.84 - $4.52 $292,113 - $464,913	-102,857 Reduced 8.79%	1,066,717 $3.23 Million
Q4 2021 Feb 14, 2022	BUY	$3.87 - $6.59 $69,230 - $117,888	17,889 Added 1.55%	1,169,574 $5.22 Million
Q3 2021 Nov 12, 2021	BUY	$6.22 - $15.54 $45,144 - $112,789	7,258 Added 0.63%	1,151,685 $7.56 Million
Q2 2021 Aug 13, 2021	BUY	$10.15 - $17.25 $11.6 Million - $19.7 Million	1,144,427 New	1,144,427 $18.3 Million

Others Institutions Holding STIM

# of Institutions

109

Shares Held

19.5M

Call Options Held

96.2K

Put Options Held

58.4K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $106M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Neuronetics, Inc. Transaction History